Aztech Global's Earnings Visibility Set to Improve -- Market Talk

Dow Jones

05/04

0220 GMT - Aztech Global's earnings visibility is poised to improve, UOB Kay Hian analysts say in a report. The electronics maker secured 27 new projects in 2025 with only eight entering commercial production then, the analysts note. Hence, the company is scheduled to start production for the rest in 2026, which offers a clearer growth pipeline, the analysts add. Also, Aztech Global's Malaysia facility obtained a U.S. FDA registration in January, which strengthens its ability to capture high-value medical technology opportunities. The brokerage lifts its 2026 and 2027 revenue forecasts for the Singapore-listed company by 15% and 22%, respectively. It upgrades its rating on the stock to buy from hold and raises its target price to S$1.32 from S$0.58. Shares are 4.4% lower at S$0.985. (ronnie.harui@wsj.com)

(END) Dow Jones Newswires

May 03, 2026 22:20 ET (02:20 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2632828449"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2632828449\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2632828449?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 10:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632828449","market":"us","top_or_hot":-1,"title":"Aztech Global's Earnings Visibility Set to Improve -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0220 GMT - Aztech Global's earnings visibility is poised to improve, UOB Kay Hian analysts say in a report. The electronics maker secured 27 new projects in 2025 with only eight entering commercial production then, the analysts note. Hence, the company is scheduled to start production for the rest in 2026, which offers a clearer growth pipeline, the analysts add. Also, Aztech Global's Malaysia facility obtained a U.S. FDA registration in January, which strengthens its ability to capture high-value medical technology opportunities. The brokerage lifts its 2026 and 2027 revenue forecasts for the Singapore-listed company by 15% and 22%, respectively. It upgrades its rating on the stock to buy from hold and raises its target price to S$1.32 from S$0.58. Shares are 4.4% lower at S$0.985. (ronnie.harui@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 03, 2026 22:20 ET (02:20 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aztech Global's Earnings Visibility Set to Improve -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAztech Global's Earnings Visibility Set to Improve -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-04 10:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0220 GMT - Aztech Global's earnings visibility is poised to improve, UOB Kay Hian analysts say in a report. The electronics maker secured 27 new projects in 2025 with only eight entering commercial production then, the analysts note. Hence, the company is scheduled to start production for the rest in 2026, which offers a clearer growth pipeline, the analysts add. Also, Aztech Global's Malaysia facility obtained a U.S. FDA registration in January, which strengthens its ability to capture high-value medical technology opportunities. The brokerage lifts its 2026 and 2027 revenue forecasts for the Singapore-listed company by 15% and 22%, respectively. It upgrades its rating on the stock to buy from hold and raises its target price to S$1.32 from S$0.58. Shares are 4.4% lower at S$0.985. (ronnie.harui@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 03, 2026 22:20 ET (02:20 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6062","symbol_name":"电子制造服务","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2632828449","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2632828449","pubTimestamp":1777861200,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0220 GMT - Aztech Global's earnings visibility is poised to improve, UOB Kay Hian analysts say in a report. The electronics maker secured 27 new projects in 2025 with only eight entering commercial production then, the analysts note. Hence, the company is scheduled to start production for the rest in 2026, which offers a clearer growth pipeline, the analysts add. Also, Aztech Global's Malaysia facility obtained a U.S. FDA registration in January, which strengthens its ability to capture high-value medical technology opportunities. The brokerage lifts its 2026 and 2027 revenue forecasts for the Singapore-listed company by 15% and 22%, respectively. It upgrades its rating on the stock to buy from hold and raises its target price to S$1.32 from S$0.58. Shares are 4.4% lower at S$0.985. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6062":"电子制造服务","8AZ.SI":"Aztech Gbl","BK6504":"工业制品概念"},"translate_title":"Aztech Global的盈利可见性将提高——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"8AZ.SI":0.9},"content_text":"0220 GMT - Aztech Global's earnings visibility is poised to improve, UOB Kay Hian analysts say in a report. The electronics maker secured 27 new projects in 2025 with only eight entering commercial production then, the analysts note. Hence, the company is scheduled to start production for the rest in 2026, which offers a clearer growth pipeline, the analysts add. Also, Aztech Global's Malaysia facility obtained a U.S. FDA registration in January, which strengthens its ability to capture high-value medical technology opportunities. The brokerage lifts its 2026 and 2027 revenue forecasts for the Singapore-listed company by 15% and 22%, respectively. It upgrades its rating on the stock to buy from hold and raises its target price to S$1.32 from S$0.58. Shares are 4.4% lower at S$0.985. (ronnie.harui@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 03, 2026 22:20 ET (02:20 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}